On September 4, 2026, Novartis announced the topline results of its phase 3 Lp(a)HORIZON trial. Novartis shared that while pelacarsen lowered lipoprotein(a) [Lp(a)] levels, the trial failed to reduce the risk of major adverse cardiovascular events (MACE). The full clinical trial results are not yet available. Lp(a) remains an important and independent risk factor for ASCVD. Clinicians and patients should continue to measure Lp(a). The Lp(a)HORIZON trial is the first of several clinical trials underway to test the impact of lowering Lp(a) on reducing MACE. Read the NLA's full statement & access Lp(a) resources at lipid.org/resource/top-line-….

Congratulations to our 2026 #NLASessions Abstract Award Winners! The research presented this year was nothing short of extraordinary, and a true reflection of the exciting developments shaping the future of lipidology. 🏆 Hunninghake Familial Hypercholesterolemia (FH) Award Jose Lopez, MS "Early Detection of Familial Hypercholesterolemia Through Point of Care Testing in 2-Year-Olds" 🥇 1st Place Jianing Li, MD "GLP-1 Receptor Agonists Rarely Cause Acute Pancreatitis but Induce Noninflammatory Acinar Hypertrophy, Pancreatic Enlargement and Mild Lipase Leak" 🥈 2nd Place Jeremy Skinner, BS "Accelerating Lipoprotein(a) Testing in Community Health Centers Through Quality Improvement and Education" 🥉 3rd Place Christie Ballantyne, MD @CBallantyneMD "Pooled Efficacy and Safety of Enlicitide, an Oral PCSK9 Inhibitor, Across Two Phase 3 Trials: CORALreef Lipids and CORALreef HeFH" Explore their research and the full Poster Hall at the link below.👇 🔗 lipidjournal.com/issue/S1933… #Lipidology #CardiometabolicHealth #PreventiveCardiology #Research

The NLA and @foundationofnla are on the floor at #ACC26! @ACCintouch We're here for all the big discussions, especially around the 2026 ACC/AHA/Multisociety Dyslipidemia Guideline and the latest in #PreventiveCardiology. Find us at booth 2353 for patient and clinician resources. Come say hi!👋 #Lipidology #Dyslipidemia #Cardiology

New to the field of lipidology and looking to jumpstart your career?🚀 Hear from Lipid Scholarship Recipient Lonnell Gant-Adenyi, DNP as she shares how attending #NLASessions helped shape her path in cardiometabolic care. If you're an early-career clinician interested in lipidology, this is the place to learn, connect, and grow!🌟 Register now: lipid.org/sessions #Lipidology #PreventiveCardiology #MedicalEducation #HealthcareProfessionals